|
|
|
Insider
Information: |
Patel Sanj K |
Relationship: |
|
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
79,551 |
|
Indirect Shares
|
109,795 |
|
|
Direct
Value |
$1,945,022 |
|
|
Indirect Value
|
$2,684,488 |
|
|
Total
Shares |
189,346 |
|
|
Total
Value |
$4,629,510 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Synageva BioPharma Corp |
GEVA |
President & CEO, Direc... |
2015-06-22 |
0 |
2015-06-22 |
0 |
Premium* |
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-09-02 |
79,551 |
2024-09-02 |
109,795 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
99 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 4
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
GEVA |
Synageva BioPharma Corp |
Director and President/CEOOffi |
|
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,031 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
Director and President/CEOOffi |
|
2011-11-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
286 |
|
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-03-23 |
4 |
OE |
$0.95 |
$47,500 |
D/D |
50,000 |
51,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-03-23 |
4 |
AS |
$33.53 |
$1,676,410 |
D/D |
(50,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-08-31 |
4 |
OE |
$0.95 |
$14,428 |
D/D |
15,187 |
16,218 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-08-31 |
4 |
AS |
$49.88 |
$757,518 |
D/D |
(15,187) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-09-04 |
4 |
AS |
$49.36 |
$2,705,372 |
D/D |
(54,813) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-09-04 |
4 |
OE |
$0.95 |
$52,072 |
D/D |
54,813 |
55,844 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-11-30 |
4 |
OE |
$0.95 |
$4,750 |
D/D |
5,000 |
6,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-11-30 |
4 |
AS |
$48.87 |
$244,326 |
D/D |
(5,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-03 |
4 |
OE |
$0.95 |
$28,500 |
D/D |
30,000 |
31,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-03 |
4 |
AS |
$49.42 |
$1,482,492 |
D/D |
(30,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-04 |
4 |
AS |
$49.34 |
$1,134,850 |
D/D |
(23,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-04 |
4 |
OE |
$0.95 |
$21,850 |
D/D |
23,000 |
24,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-05 |
4 |
OE |
$0.95 |
$11,400 |
D/D |
12,000 |
13,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-05 |
4 |
AS |
$48.10 |
$577,255 |
D/D |
(12,000) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-13 |
4 |
OE |
$0.95 |
$13,680 |
D/D |
14,400 |
15,431 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-13 |
4 |
AS |
$45.12 |
$657,470 |
D/D |
(14,400) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-14 |
4 |
AS |
$45.30 |
$601,629 |
D/D |
(13,281) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-14 |
4 |
OE |
$0.95 |
$12,617 |
D/D |
13,281 |
14,312 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-17 |
4 |
OE |
$0.95 |
$30,703 |
D/D |
32,319 |
33,350 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2012-12-17 |
4 |
AS |
$45.97 |
$1,513,338 |
D/D |
(32,319) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2013-02-20 |
4 |
OE |
$0.95 |
$23,378 |
D/D |
24,608 |
25,639 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2013-02-20 |
4 |
AS |
$49.49 |
$1,218,505 |
D/D |
(24,608) |
1,031 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
President & CEO |
|
2013-02-21 |
4 |
AS |
$49.02 |
$2,225,116 |
D/D |
(45,392) |
1,031 |
0 |
- |
|
99 Records found
|
|
Page 1 of 4 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|